醫療設備報銷市場：成長機會、成長要素、產業趨勢分析及 2026-2035 年預測。

全球醫療設備報銷市場預計到 2025 年將達到 6,176 億美元，預計到 2035 年將以 6.5% 的複合年成長率成長至 1.2 兆美元。

市場擴張的促進因素包括醫療成本上升、慢性病盛行率增加以及政府為促進醫療設備普及而採取的支持措施。此外，基於價值的醫療模式的採用正在重塑報銷框架，強調臨床療效和成本效益。醫療設備報銷是指醫療服務提供者（例如醫院、診所和手術中心）在診斷、監測和治療中使用醫療器材的購置、維護和使用所獲得的補償。隨著新的支付模式、資格標準和市場准入管道的出現，報銷結構也在不斷發展，這為能夠改善患者預後並降低整體醫療成本的創新醫療器材創造了機會。這些變革性趨勢正在加強醫療設備與現代醫療體系的融合，同時確保其財務永續性。

預計到2025年，私人保險公司市佔率將達到63.3%。與公共保險公司相比，私人保險公司、雇主提供的保險計劃和補充保險通常能提供更快的理賠核准速度和更優惠的賠付率。此外，私人保險更有可能承保先進的高階醫療設備。這一領域的成長主要得益於中高所得者的增加，尤其是在私人保險滲透率較高的亞太地區。

截至2025年，醫院領域將佔50.8%的市佔率。醫院的報銷範圍將涵蓋住院、門診、門診手術中心和急診。推動這一成長的主要因素是手術數量的增加、先進技術的應用以及複雜手術報銷範圍的擴大。許多醫療設備的報銷並非以單一器械計算，而是採用打包支付模式，例如手術費和診斷相關分組（DRG）支付。

預計到2025年，北美醫療設備報銷市佔率將達到47.2%。美國市場受惠於龐大的醫療保健經濟、完善的報銷系統、清晰的監管以及醫療技術的先進應用。公共和私人支出確保了高階醫療設備的保險覆蓋，從而支撐了市場穩定。

目錄

第1章：調查方法

• 研究途徑
• 品質改進計劃
  • GMI人工智慧政策及對資料完整性的承諾
    • 資訊來源一致性通訊協定
• 調查過程和可靠性評分
  • 研究路徑的組成部分
  • 評分組成部分
• 數據收集
  • 主要來源部分列表
• 資料探勘資訊來源
  • 付費資訊來源
    • 區域資訊來源
• 基本估算和計算方法
  • 基準年的計算
• 預測模型
  • 量化市場影響分析
    • 生長參數對預測的數學影響
• 關於調查透明度的補充資訊
  • 資訊來源歸屬框架
  • 品質保證指標
  • 對信任的承諾

第2章執行摘要

第3章業界考察

• 生態系分析
• 影響產業的因素
  • 促進因素
    • 慢性病盛行率增加
    • 引入基於價值的醫療保健模式
    • 醫療費用不斷上漲帶來的負擔
    • 政府扶持計劃
  • 產業潛在風險與挑戰
    • 複雜的還款框架
    • 少付發票金額或拒收發票。
  • 機會
    • 擴大遠端患者監護的報銷範圍
    • 政府和私人對醫療保健領域的投資
• 成長潛力分析
• 監理情勢
• 科技與創新趨勢
  • 當前技術趨勢
  • 新興技術
• 政策舉措
• 編碼系統概述
• 贖回模式展望
• 在政策和促進和諧方面存在區域差異
• 波特五力分析
• PESTEL 分析
• 差距分析
• 未來市場趨勢

第4章 競爭情勢

• 介紹
• 企業矩陣分析
• 企業市佔率分析
  • 世界
  • 北美洲
  • 歐洲
  • 亞太地區
• 主要市場公司的競爭分析
• 競爭定位矩陣
• 主要進展
  • 併購
  • 夥伴關係與合作
  • 新產品發布
  • 業務拓展計劃

第5章 市場估計與預測：依支付方分類，2022-2035年

• 民眾
• 私人的

第6章 市場估計與預測：依醫療機構分類，2022-2035年

• 醫院
• 門診設施
• 其他醫療機構

第7章 市場估計與預測：依地區分類，2022-2035年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第8章：公司簡介

• Allianz
• Anthem Insurance Companies, Inc.
• Aviva
• BNP Paribas
• Cigna
• CVS Health
• Experian Health
• Humana Inc.
• Nippon Life Insurance Company
• United Health Group
• WellCare Health Plans, Inc.

The Global Medical Devices Reimbursement Market was valued at USD 617.6 billion in 2025 and is estimated to grow at a CAGR of 6.5% to reach USD 1.2 trillion by 2035.

The market expansion is driven by rising healthcare expenditures, increasing prevalence of chronic illnesses, and supportive government initiatives promoting access to medical devices. The adoption of value-based healthcare models has also reshaped reimbursement frameworks, emphasizing clinical effectiveness and cost-efficiency. Medical device reimbursement involves compensating healthcare providers, including hospitals, clinics, and surgical centers, for the acquisition, maintenance, and use of devices in diagnosis, monitoring, and treatment. Reimbursement structures are evolving with new payment models, coverage criteria, and market access pathways, creating opportunities for innovative devices that improve patient outcomes and reduce overall healthcare costs. These transformative trends are strengthening the integration of medical devices into modern healthcare systems while ensuring financial sustainability.

The private payer segment held a 63.3% share in 2025. Private insurers, employer-sponsored plans, and supplemental policies generally offer faster coverage decisions and more favorable payment rates than public payers. Private coverage is also more likely to include advanced or premium devices. Growth in this segment is supported by rising middle- and high-income populations, particularly in the Asia-Pacific region, where private insurance adoption is increasing.

The hospitals segment accounted for 50.8% share in 2025. Reimbursement in hospitals includes inpatient, outpatient, ambulatory surgical centers, and emergency departments. Growth is fueled by higher surgical volumes, adoption of advanced technologies, and broader reimbursement for complex procedures. Many devices are reimbursed as part of bundled payments, such as procedure fees or diagnosis-related groups, rather than on an individual device basis.

North America Medical Devices Reimbursement Market held 47.2% share in 2025. The U.S. market benefits from a large healthcare economy, established reimbursement infrastructure, regulatory clarity, and advanced adoption of medical technologies. Public and private spending ensures coverage for premium medical devices and supports market stability.

Key players in the Global Medical Devices Reimbursement Market include Allianz, Anthem Insurance Companies, Inc., Aviva, BNP Paribas, Cigna, CVS Health, Experian Health, Humana Inc., Nippon Life Insurance Company, United Health Group, and WellCare Health Plans, Inc. Companies in the Medical Devices Reimbursement Market strengthen their presence through multiple strategies. They focus on expanding private payer partnerships, offering tailored coverage plans for innovative devices, and negotiating favorable payment terms. Investments in digital claims management, real-time reimbursement analytics, and regulatory compliance tools improve operational efficiency. Firms also develop education programs for healthcare providers to increase adoption of reimbursed devices and demonstrate clinical and economic value. Strategic collaborations with hospitals, insurers, and technology providers enhance market penetration, while ongoing monitoring of evolving policies ensures adaptability to new payment models.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Payer trends
  • 2.2.3 Healthcare setting trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of chronic diseases
    • 3.2.1.2 Adoption of value-based healthcare models
    • 3.2.1.3 Growing burden of healthcare cost
    • 3.2.1.4 Supportive government programs
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Complex reimbursement framework
    • 3.2.2.2 Underpayment or denial of claims
  • 3.2.3 Opportunities
    • 3.2.3.1 Growth in remote patient monitoring reimbursement
    • 3.2.3.2 Government & private investment in healthcare
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 MEA
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Policy initiatives
• 3.7 Coding systems overview
• 3.8 Reimbursement models outlook
• 3.9 Regional policy differences & harmonization efforts
• 3.10 Porter's analysis
• 3.11 PESTEL analysis
• 3.12 Gap analysis
• 3.13 Future market trends

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Payer, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Public
• 5.3 Private

Chapter 6 Market Estimates and Forecast, By Healthcare Setting, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals
• 6.3 Outpatient facilities
• 6.4 Other settings

Chapter 7 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 MEA
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 Allianz
• 8.2 Anthem Insurance Companies, Inc.
• 8.3 Aviva
• 8.4 BNP Paribas
• 8.5 Cigna
• 8.6 CVS Health
• 8.7 Experian Health
• 8.8 Humana Inc.
• 8.9 Nippon Life Insurance Company
• 8.10 United Health Group
• 8.11 WellCare Health Plans, Inc.